Insights

Scaling up external innovation in the neurodegenerative disease landscape

Shaping the Future of Neurodegenerative Diseases: Avertim’s Strategic…

Using Agile PM to drive improvement in Pharma

Agile project management is well known-for its success in software. The pha…

Quality Event Management: a challenge for the Pharmaceutical sector

The close relationship between quality and production processes Quality is …

How blockchain can really change the world of clinical trials?

How blockchain can really change the world of clinical trials? In clinical …

Avertim as a speaker at the A3P event!

Good Manufacturing Practices in a box – The future of aseptic product…

(Total) Recall: Chronicle of an announced war against nitrosamines

When the risk of cancer linked to anti-smoking drugs outweighs the risk lin…

Is the traditional « One size fits all » blockbuster model dying?

“One size fits all” has long been the norm in the world of medi…

Future of health and healthcare

This article of the World Economic Forum is a pledge for out-of-the-box thi…

Whitepaper: digital solutions across the pharma value chain

The pharmaceutical industry is currently undergoing an unprecedented transf…

Top 3 challenges in COVID-19 vaccine development vs traditional vaccines

The current COVID-19 pandemic is spreading with high speed. It took six mon…

Vaccine technologies for the battle against COVID-19 pandemic

Avertim has been working in the Life Sciences sector for more than a decade…

166 vaccines in the race against COVID-19 – Germany among the frontrunners

Driven by the impact of the current COVID-19 pandemic on the global healthc…